Absolute Peptides UK
Tirzepatide pen 20mg
Tirzepatide pen 20mg
Couldn't load pickup availability
Product Overview
Tirzepatide targets both glucose dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
| Compound | Tirzepatide |
| Full name | GIP / GLP-1 receptor dual agonist |
| Molecular weight | 4813.45 g/mol |
| Molecular formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| CAS number | 2023788-19-2 |
| Purity (HPLC) | 99.5%+ |
| Mass confirmation | LC-MS confirmed |
| Residual moisture | < 3.0% (Karl Fischer) |
| Form | Lyophilised powder |
| Solubility | Bacteriostatic water |
| Storage | -20°C lyophilised, 24 months |
Research Use Notice
This product is supplied exclusively for legitimate laboratory research and analytical purposes. It is not for human or veterinary use, therapeutic use, diagnostic use, cosmetic use or as a food or dietary supplement.
Product specifications are provided for scientific reference only and should not be interpreted as medical advice or as a guarantee of suitability for any application outside laboratory research. Please refer to our Research Use Disclaimer for further information.
Want to understand these technical specifications?
Learn more about HPLC, LC-MS, Karl Fischer moisture analysis, molecular weight, CAS numbers and lyophilisation on our Analytical Methods page.
Share
